Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNA2 | P20248 | 3/20 | 0.66 |
| ▸ | CDK2 | P24941 | 3/20 | 0.66 |
| ▸ | IGF1R | P08069 | 7/20 | 0.52 |
| ▸ | NTRK1 | P04629 | 5/20 | 0.50 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12783887 | 0.89 | CCNA2 (0.68) | CCNA2CDK2IGF1RNTRK1NUAK1 | |
| SCHEMBL12878463 | 0.87 | CCNA2 (0.74) | CCNA2CDK2IGF1RNTRK1 | |
| SCHEMBL12784897 | 0.86 | CCNA2 (0.65) | CCNA2CDK2IGF1RNTRK1NUAK1 | |
| SCHEMBL12784885 | 0.85 | CCNA2 (0.64) | CCNA2CDK2IGF1RNTRK1 | |
| SCHEMBL12878583 | 0.85 | CCNA2 (0.68) | CCNA2CDK2IGF1RNTRK1 | |
| SCHEMBL12783990 | 0.83 | CCNA2 (0.79) | CCNA2CDK2IGF1RNTRK1 | |
| SCHEMBL16001668 | 0.82 | CCNA2 (0.67) | CCNA2CDK2IGF1RNTRK1 | |
| SCHEMBL12784003 | 0.82 | CCNA2 (0.71) | CCNA2CDK2IGF1RNTRK1 | |
| SCHEMBL12784877 | 0.82 | CCNA2 (0.59) | CCNA2CDK2IGF1RNTRK1 | |
| SCHEMBL12784486 | 0.81 | CCNA2 (0.66) | CCNA2CDK2IGF1RNTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011019405-A1 | PYRIMIDINE COMPOUNDS AS TUBERCULOSIS INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-02-17 | — | — | WO | disclosed |